Antimicrobial Efficacy and Safety of a Novel Gas Plasma-Activated Catheter Lock Solution

Antimicrobial Agents and Chemotherapy
Sudhir BhattMichael G Kong

Abstract

Antimicrobial lock solutions are important for prevention of microbial colonization and infection of long-term central venous catheters. We investigated the efficacy and safety of a novel antibiotic-free lock solution formed from gas plasma-activated disinfectant (PAD). Using a luminal biofilm model, viable cells of methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Candida albicans in mature biofilms were reduced by 6 to 8 orders of magnitude with a PAD lock for 60 min. Subsequent 24-h incubation of PAD-treated samples resulted in no detectable regrowth of viable bacteria or fungi. As a comparison, the use of a minocycline-EDTA-ethanol lock solution for 60 min led to regrowth of bacteria and fungi, up to 107 to 109 CFU/ml, in 24 h. The PAD lock solution had minimal impact on human umbilical vein endothelial cell viability, whereas the minocycline-EDTA-ethanol solution elicited cell death in nearly half of human endothelial cells. Additionally, PAD treatment caused little topological change to catheter materials. In conclusion, PAD represents a novel antibiotic-free, noncytotoxic lock solution that elicits rapid and broad-spectrum eradication of biofilm-laden microbes and shows ...Continue Reading

References

Mar 1, 1988·JPEN. Journal of Parenteral and Enteral Nutrition·B MessingJ J Bernier
May 23, 2002·Antimicrobial Agents and Chemotherapy·Chirag B ShahLeonard A Mermel
Nov 8, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hans-Dietrich Polaschegg, Klaus Sodemann
Dec 6, 2003·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Hans-Dietrich Polaschegg, Chirag Shah
Jun 15, 2007·Applied and Environmental Microbiology·Georges Kamgang-YoubiMurielle Naïtali
Jun 22, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I RaadK Rolston
Dec 3, 2008·Blood Reviews·Leon J Worth, Monica A Slavin
Feb 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jiong HuZhu Chen
Feb 11, 2011·Journal of Visualized Experiments : JoVE·George A O'Toole
Jan 11, 2012·Antimicrobial Agents and Chemotherapy·Erik KvamAllen L Garner
Oct 17, 2012·Antimicrobial Agents and Chemotherapy·Carla J Walraven, Samuel A Lee
Jan 25, 2013·The New England Journal of Medicine·Brad SpellbergDavid N Gilbert
May 23, 2013·The Journal of Biological Chemistry·Claudia LindemannLars I Leichert
Oct 9, 2013·Current Opinion in Nephrology and Hypertension·Vandana D Niyyar, Charmaine E Lok
Mar 19, 2014·International Journal of Antimicrobial Agents·Anne Mai-ProchnowKostya Ken Ostrikov
Jun 4, 2014·The Journal of Antimicrobial Chemotherapy·Leonard A Mermel, Neha Alang
Jun 11, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jonas MarschallDeborah S Yokoe
Nov 21, 2014·Nutrients·William T ClementsRichard J Bloomer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Kerry L LaPlante, Leonard A Mermel
Antimicrobial Agents and Chemotherapy
Chirag B ShahLeonard A Mermel
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde
Hua Yan, Jun Li
Minerva anestesiologica
A DavidA U Sinardi
© 2022 Meta ULC. All rights reserved